MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • MDS Virtual Congress 2021

    Acute Onset, Unilateral Restless Leg Syndrome after Subthalamic Nucleus Deep Brain Stimulation

    M. Bock, R. Zuzuarregui (San Francisco, USA)

    Objective: To describe a case of acute onset, unilateral restless leg syndrome (RLS) after  subthalamic nucleus (STN) deep brain stimulation (DBS) for Parkinson’s disease. Background:…
  • MDS Virtual Congress 2021

    Autoimmunity may contribute to peri-electrode edema after deep brain stimulation for Parkinson’s disease: a case series

    AD. Magalhães, L. Kauppila, P. Lobo, L. Guedes, M. Rosa, H. Carvalho, B. Cattoni, M. Coelho (Lisboa, Portugal)

    Objective: To identify and characterize cases of symptomatic peri-electrode edema after DBS. Background: Peri-electrode edema is a rare complication of Deep Brain Stimulation (DBS) surgery.…
  • MDS Virtual Congress 2021

    PKG for the management of advance Parkinson’s Disease

    S. Duja (Dudley, United Kingdom)

    Objective: Is PKG an effective way of monitoring advanced PD patients? Is it cost effective? Can PKG be used to review and manage patients virtually? Can PKG…
  • MDS Virtual Congress 2021

    Efficacy of the ankle bracelet-laser to improve gait in Parkinson disease (PD).

    P. Ruthiraphong, C. Ratanasutiranont, K. Srisilpa (Bangkok, Thailand)

    Objective: To assess the efficacy of the ankle bracelet-laser in improving gait parameters and functional performance in Parkinson patients with freezing of gait (FOG) Background:…
  • MDS Virtual Congress 2021

    Comparison of pre – and post – clinical outcomes after COVID-19 lockdown in people with Parkinson’s in Portugal

    C. Godinho, D. Tavares, J. Dean, J. Domingos (Sintra, Portugal)

    Objective: We compare several pre- and post-clinical outcomes to assess the effects in a group of Portuguese people with PD. Background: Government-mandated restrictions due to…
  • MDS Virtual Congress 2021

    Movement Disorder Fellowships: Assessment and Recruitment Strategies to Meet Clinical Needs

    M. Rashid, A. Zafar, J. Owens, G. Patino, M. Robbins, S. Sandrone, H. Sarva (Ottawa Hills, USA)

    Objective: 1. Identify factors leading to lower number of residents interested in movement disorders fellowship. 2. Propose strategies to increase recruitment. Background: The prevalence of…
  • MDS Virtual Congress 2021

    Characteristics and outcomes of Parkinson’s disease individuals hospitalized with COVID-19 in a New York City hospital system

    L. Nwabuobi, C. Zhang, C. Henchcliffe, H. Shah, H. Sarva, A. Lee, H. Kamel (New York, USA)

    Objective: To determine the clinical characteristics and outcomes in hospitalized individuals with Parkinson's disease (PD) infected with COVID-19 Background: The COVID-19 pandemic has caused worse…
  • MDS Virtual Congress 2021

    Evaluation of Care delivery model for integrated care and self-management for people with Parkinson’s disease with Deep Brain Stimulation

    D. Dash, D. Cote, J. Conway, A. Basndwah, D. Grimes, T. Mestre (Ottawa, Canada)

    Objective: To evaluate the implementation and impact potential of a pragmatic network for PD care, the Integrated Parkinson Care Network (IPCN) for patients with chronic…
  • MDS Virtual Congress 2021

    Tele and video consultations of patients with parkinsonism in the Brazilian public health system – a real life feasibility study

    D. Dos Santos, D. Freire Camelo, M. Strelow, M. Silva, P. Führ, L. Marins, A. Schumacher-Schuh (Porto Alegre, Brazil)

    Objective: To evaluate the feasibility and identify obstacles in conducting teleconsultations for patients with parkinsonism in the Brazilian public health system Background: Patients with parkinsonism…
  • MDS Virtual Congress 2021

    Phase 1/2 Open-label Dose Evaluation Study of AXO-Lenti-PD Gene Therapy for Parkinson’s Disease: Efficacy, Safety, and Tolerability Data from the Second Cohort at 6 Months

    G. Corcoran, A. Karunakara, B. Vaughn, E. Brand-Schieber, T. Foltynie, R. Barker, S. Palfi (New York, USA)

    Objective: Results from cohort 2 in the Phase 1/2 SUNRISE-PD study (NCT03720418) at 6 months (6M) post administration of AXO-Lenti-PD (ALPD) gene therapy are presented.…
  • « Previous Page
  • 1
  • …
  • 332
  • 333
  • 334
  • 335
  • 336
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • VIT-D and Tics Movement Disorder
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley